Use of sapropterin in Mexican patients with yperphenylalaninemia

• Egile Nagusiak: Susana Monroy-Santoyo (Egilea), Leticia Belmont-Martínez (Egilea), Cynthia Fernández-Lainez (Egilea)
• Formatua: Liburua
• Argitaratua: Instituto Nacional de Pediatría, 2014-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Hyperphenylalaninemia is caused by deficient enzyme activity of phenylalanine hydroxylase. It was one of the first genetic disorders susceptible to treatment with a natural protein restricted diet for life. While this treatment has proven effective in preventing mental retardation, eliminating certa...